Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Connect Biopharma Holdings (CNTB) Cash from Investing Activities (2024 - 2025)

Connect Biopharma Holdings' Cash from Investing Activities history spans 2 years, with the latest figure at $14.3 million for Q3 2025.

  • For Q3 2025, Cash from Investing Activities rose 9859.18% year-over-year to $14.3 million; the TTM value through Sep 2025 reached -$16.9 million, changed N/A, while the annual FY2024 figure was -$3.5 million, 104.6% down from the prior year.
  • Cash from Investing Activities for Q3 2025 was $14.3 million at Connect Biopharma Holdings, up from $5.1 million in the prior quarter.
  • Across five years, Cash from Investing Activities topped out at $14.3 million in Q3 2025 and bottomed at -$20.6 million in Q1 2025.